The unseen connection: laryngeal carcinoma and thrombosis of the internal jugular vein
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
The occlusion of the internal jugular vein (IJV) in the context of laryngeal carcinoma is a rare but significant occurrence that may manifest at various stages of the disease. Laryngeal carcinoma, a form of cancer affecting the voice box, carries profound implications for individuals and society alike. Although the primary focus often lies in treating cancer, emerging research has uncovered an intriguing link between laryngeal carcinoma and jugular vein thrombosis (JVT), necessitating further investigation. We conducted a retrospective study spanning from January 2020 to December 2023, analyzing data from 60 patients who underwent surgery for laryngeal carcinoma at the Ear, Nose and Throat Department of the University Clinical Center of Kosovo. Among them, 9 patients were identified with concurrent IJV thrombosis, discovered incidentally during computed tomography examinations or based on clinical symptoms. Logistic regression analysis revealed associations between laryngeal carcinoma and JVT, emphasizing the importance of vigilance in diagnosis and management. Our findings underscore the need for heightened awareness and preventive measures, particularly in high-risk patients, to mitigate the impact of this interrelated condition. Early detection and intervention are crucial in optimizing outcomes for individuals confronting the dual challenges of laryngeal carcinoma and JVT.
How to Cite

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.